Adaptive responses to neurodegenerative stress in glaucoma.
AI Summary
Glaucoma research reveals RGCs initially adapt to stress via enhanced excitability and astrocyte metabolic support, but these transient mechanisms ultimately fail, highlighting the disease's progressive nature.
Abstract
Glaucoma causes loss of vision through degeneration of the retinal ganglion cell (RGC) projection to the brain. The disease is characterized by sensitivity to intraocular pressure (IOP) conveyed at the optic nerve head, through which RGC axons pass unmyelinated to form the optic nerve. From this point, a pathogenic triumvirate comprising inflammatory, oxidative, and metabolic stress influence both proximal structures in the retina and distal structures in the optic projection. This review focuses on metabolic stress and how the optic projection may compensate through novel adaptive mechanisms to protect excitatory signaling to the brain. In the retina and proximal nerve head, the unmyelinated RGC axon segment is energy-inefficient, which leads to increased demand for adenosine-5'-triphosphate (ATP) at the risk of vulnerability to Ca 2+ -related metabolic and oxidative pressure. This vulnerability may underlie the bidirectional nature of progression. However, recent evidence highlights that the optic projection in glaucoma is not passive but rather demonstrates adaptive processes that may push back against neurodegeneration. In the retina, even as synaptic and dendritic pruning ensues, early progression involves enhanced excitability of RGCs. Enhancement involves depolarization of the resting membrane potential and increased response to light, independent of RGC morphological type. This response is axogenic, arising from increased levels and translocation of voltage-gated sodium channels (NaV) in the unmyelinated segment. During this same early period, large-scale networks of gap-junction coupled astrocytes redistribute metabolic resources to the optic projection stressed by elevated IOP to slow loss of axon function. This redistribution may reflect more local remodeling, as astrocyte processes respond to focal metabolic duress by boosting glycogen turnover in response to axonal activity in an effort to promote survival of the healthiest axons. Both enhanced excitability and metabolic redistribution are transient, indicating that the same adaptive mechanisms that apparently serve to slow progression ultimately may be too expensive for the system to sustain over longer periods.
MeSH Terms
Shields Classification
Key Concepts6
In the retina and proximal nerve head, the unmyelinated retinal ganglion cell (RGC) axon segment is energy-inefficient, leading to increased demand for adenosine-5'-triphosphate (ATP) and vulnerability to Ca2+-related metabolic and oxidative pressure in glaucoma.
Early progression of glaucoma involves enhanced excitability of retinal ganglion cells (RGCs) in the retina, characterized by depolarization of the resting membrane potential and increased response to light, independent of RGC morphological type.
Enhanced excitability of retinal ganglion cells (RGCs) in early glaucoma is axogenic, arising from increased levels and translocation of voltage-gated sodium channels (NaV) in the unmyelinated segment.
During early glaucoma, large-scale networks of gap-junction coupled astrocytes redistribute metabolic resources to the optic projection stressed by elevated intraocular pressure (IOP) to slow the loss of axon function.
Glaucoma is characterized by sensitivity to intraocular pressure (IOP) conveyed at the optic nerve head, through which retinal ganglion cell (RGC) axons pass unmyelinated to form the optic nerve.
In glaucoma, a pathogenic triumvirate comprising inflammatory, oxidative, and metabolic stress influences both proximal structures in the retina and distal structures in the optic projection.
Related Articles5
Glaucoma and neuroinflammation: An overview.
ReviewTranslational neuroprotection research in glaucoma: a review of definitions and principles.
ReviewWhat changes can we expect in the brain of glaucoma patients?
ReviewLack of immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma.
Basic ScienceRelevance of the site of injury of glaucoma to neuroprotective strategies.
ReviewIs this article assigned to the wrong chapter(s)? Let us know.